ABX
Abacus Global Management, Inc.
ABX's fundamentals are strong: revenue grew 65% and its operating margin rose 11 points to 32%. At 33x earnings, it's trading right at its usual valuation. Analysts expect that strong growth to continue.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
ABX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
ABX's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like ABX.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
ABX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.7x | $8.78 | — |
| Cheap | 25x | $6.77 | -23% |
| Fair | 32x | $8.54 | -2.7% |
| Current | 33x | $8.78 | — |
| Expensive | 209x | $56.46 | +543% |
Historical ranges are pointers, not guarantees.
ABX's PE is in its fair range at 33x. If earnings grow as analysts expect, today's price would be 7.7x next year's earnings, in its cheap range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
ABX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for ABX, with profitability holding steady.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ABX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.14 | +324% |
| Q2 2026 | $0.27 | +$0.37 |
| Q1 2026 | $0.38 | +$0.65 |
| Q4 2025 | $0.36 | +$0.70 |
| Q3 2025 | $0.04 | +$0.26 |
| Q2 2025 | -$0.10 | +$0.04 |
| Q1 2025 | -$0.27 | -$0.25 |
ABX has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
ABX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $73M | +30% |
| Q1 2026 | $59.4M | +35% |
| Q4 2025 | $71.9M | +116% |
| Q3 2025 | $63M | +124% |
| Q2 2025 | $56.2M | +93% |
| Q1 2025 | $44.1M | +105% |
| Q4 2024 | $33.2M | +40% |
| Q3 2024 | $28.1M | +33% |
ABX's revenue has grown year over year every quarter since early 2024: $73M last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 29% | -11 points |
| Q1 2026 | 31% | -17 points |
| Q4 2025 | 32% | +82 points |
| Q3 2025 | 36% | +11 points |
| Q2 2025 | 40% | +17 points |
| Q1 2025 | 48% | +37 points |
| Q4 2024 | -50% | -59 points |
| Q3 2024 | 24% | -5.5 points |
ABX has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
ABX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $38.4M | -49% |
| Q1 2026 | $91.6M | +$153.4M |
| Q4 2025 | -$7.6M | +$84.6M |
| Q3 2025 | -$32.9M | +$19.6M |
| Q2 2025 | $75.7M | +$142.7M |
| Q1 2025 | -$61.8M | -3036% |
| Q4 2024 | -$92.2M | -$78.7M |
| Q2 2024 | -$67M | -$29.1M |
ABX has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
ABX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.1% | -1.1M shares |
| 1 year | +1.1% | +1.1M shares |
| 3 years | +128% | +55.3M shares |
ABX has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $9.9M |
| Q1 2026 | $14.5M |
| Q4 2025 | $5.5M |
| Q3 2025 | $3.2M |
| Q2 2025 | $35.1M |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
ABX spent $33M buying back its own shares over the past year, down 5.6% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ABX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.0x | Elevated |
| Q1 2026 | 2.8x | Moderate |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.9x | High |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.5x | Net Cash |
| Q4 2024 | -18.7x | Net Cash |
| Q3 2024 | -0.2x | Net Cash |
ABX has the edge over IREN on leverage, with a lower net debt burden relative to earnings.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
ABX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.3 | Neutral |
| Stochastic | 35.8 | Neutral |
ABX's weekly RSI is 48 (neutral) and its Stochastic is 36 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
ABX PE vs Financial Services Sector
| Metric | ABX | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 13x | 150% above |
| PE % | 53 | 62 | 9 pts below |
ABX is trading at 33x earnings, a 150% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
ABX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.36 | 5% above |
| 20 week MA | $9.35 | 6.1% below |
| 50 week MA | $8.97 | 2.1% below |
| 100 week MA | $7.90 | 11% above |
| 200 week MA | $8.72 | 0.7% above |
ABX has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
ABX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.76 | $9.98 | +2.3% |
| 2021 | $9.98 | $9.86 | -1.2% |
| 2022 | $9.86 | $10.1 | +2.5% |
| 2023 | $10.1 | $9.66 | -4.5% |
| 2024 | $9.66 | $7.75 | -20% |
| 2025 | $7.75 | $8.50 | +9.7% |
| 2026 YTD | $8.50 | $8.78 | +3.3% |
ABX has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.